Biotechnology Stock List
Year-to-Date Return
-100.0%1,970.0%
10-Year Annualized Return
-100.0%120.0%
Dividend Yield
0.0%80.0%
10Y Volatility
10.0%21,980.0%
Maximum Drawdown
-100.0%-10.0%
Sharpe Ratio
-1.54.9
| Symbol | Full name | YTD Ret. | 10Y Ann. Ret. | Div. Yield | 10Y Volatility | Max. Drawdown | Sharpe Ratio |
|---|---|---|---|---|---|---|---|
| AADI | Aadi Bioscience, Inc. | -43.5% | -37.0% | N/A | 89.2% | -93.2% | -1.0 |
| ABCL | AbCellera Biologics Inc. | -25.2% | -59.4% | N/A | 74.4% | -90.3% | -0.3 |
| ABCM | Abcam plc | -15.0% | -15.3% | N/A | 41.6% | -47.8% | -0.6 |
| ABEO | Abeona Therapeutics Inc. | -11.7% | -42.0% | N/A | 103.2% | -100.0% | -0.6 |
| ABIO | ARCA biopharma, Inc. | -12.7% | -39.3% | N/A | 150.4% | -100.0% | -0.4 |
| ABOS | Acumen Pharmaceuticals, Inc. | -22.0% | -59.5% | N/A | 110.5% | -84.8% | -0.2 |
| ABSI | Absci Corporation | -17.6% | -77.9% | N/A | 97.1% | -94.8% | -0.9 |
| ABUS | Arbutus Biopharma Corporation | 31.3% | -4.2% | N/A | 94.8% | -97.2% | 0.0 |
| ABVC | ABVC BioPharma, Inc. | -2.4% | -81.7% | N/A | 965.9% | -100.0% | -0.6 |
| ACAD | ACADIA Pharmaceuticals Inc. | 16.8% | 8.9% | N/A | 68.1% | -96.3% | -0.5 |
| ACER | Acer Therapeutics Inc. | -69.8% | -42.6% | N/A | 115.8% | -100.0% | -0.6 |
| ACET | Adicet Bio, Inc. | -33.8% | -44.1% | N/A | 94.0% | -96.0% | -0.8 |
| ACHL | Achilles Therapeutics plc | -2.2% | -77.2% | N/A | 73.8% | -95.6% | -1.0 |
| ACHV | Achieve Life Sciences, Inc. | 109.4% | -57.3% | N/A | 90.8% | -100.0% | -0.5 |
| ACIU | AC Immune SA | 9.3% | -26.0% | N/A | 78.4% | -91.1% | -0.6 |
| ACLX | Arcellx Inc | -3.2% | 84.2% | N/A | 87.4% | -62.3% | 1.0 |
| ACOR | Acorda Therapeutics, Inc. | -26.0% | -44.2% | N/A | 98.2% | -99.9% | -0.3 |
| ACRS | Aclaris Therapeutics, Inc. | -48.3% | -4.0% | N/A | 111.9% | -97.7% | -0.7 |
| ACXP | Acurx Pharmaceuticals, Inc. | -10.1% | -25.6% | N/A | 78.9% | -69.3% | 0.0 |
| ADAG | Adagene Inc. | 3.4% | -76.6% | N/A | 74.9% | -97.0% | -0.9 |